In experimentally induced pancreatitis, IL-10 levels parallel serum TNF levels and anti-IL-10 treatment reduce lung injury and pancreatic acinar necrosis, as well as reducing mortality from 42% to 0%. This evidence concerns the gene IL10 and pancreatitis.